AkLief Evaluation in Acne-induced Post-Inflammatory Hyperpigmentation

Completed · Phase 4

Conditions studied: Acne Vulgaris

In brief

The purpose of this study is to evaluate the efficacy and safety of Trifarotene 50 microgram per gram (mcg/g) cream compared to its vehicle cream in the treatment of moderate acne vulgaris with risk of acne-induced post inflammatory hyperpigmentation (PIH) after 24 weeks of treatment in facial acne participants

Key facts

Study ID

NCT05089708

Run by

Galderma R&D

People needed

123

Starts

2021-12-22

Expected to finish

2022-12-15

Last updated by the study team

2023-12-20

Who can join

Age: 13 and older, up to 35. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Galderma Investigational Site #8636 — Fountain Valley, California, United States
• Galderma Investigational Site #8224 — Fremont, California, United States
• Galderma Investigational Site #8358 — San Diego, California, United States
• Galderma Investigational Site #9955 — San Diego, California, United States
• Galderma Investigational Site #7012 — Lutz, Florida, United States
• Galderma Investigational Site #8184 — Maitland, Florida, United States
• Galderma Investigational Site #8764 — Tampa, Florida, United States
• Galderma Investigational Site #9950 — Evansville, Indiana, United States
• Galderma Investigational Site #9952 — Baton Rouge, Louisiana, United States
• Galderma Investigational Site #8606 — New Orleans, Louisiana, United States
• Galderma Investigational Site #8012 — Glenn Dale, Maryland, United States
• Galderma Investigational Site #9948 — Hyattsville, Maryland, United States
• Galderma Investigational Site #8554 — Detroit, Michigan, United States
• Galderma Investigational Site #8108 — Las Vegas, Nevada, United States
• Galderma Investigational Site #8620 — New York, New York, United States
• Galderma Investigational Site #9956 — New York, New York, United States
• Galderma Investigational Site #9949 — New York, New York, United States
• Galderma Investigational Site #9953 — Tulsa, Oklahoma, United States
• Galderma Investigational Site #8207 — Nashville, Tennessee, United States
• Galderma Investigational Site #9920 — Arlington, Texas, United States
• Galderma Investigational Site #8329 — San Antonio, Texas, United States
• Galderma Investigational Site #8433 — San Antonio, Texas, United States
• Galderma Investigational Site #6192 — Zaragoza, Aragon, Spain
• Galderma Investigational Site #6278 — Manises, Valencia, Spain
• Galderma Investigational Site #6277 — Pontevedra, Spain

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.